Miranda Pans

636 total citations
10 papers, 493 citations indexed

About

Miranda Pans is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Miranda Pans has authored 10 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in Miranda Pans's work include Schizophrenia research and treatment (5 papers), Diabetes Treatment and Management (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Miranda Pans is often cited by papers focused on Schizophrenia research and treatment (5 papers), Diabetes Treatment and Management (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Miranda Pans collaborates with scholars based in Belgium, United States and Germany. Miranda Pans's co-authors include Ken Fujioka, Steven Joyal, Gilbert L’Italien, Linda Hanssens, Ronald N. Marcus, Robert D. McQuade, Cindy J. Rubin, Barry J. Goldstein, Jean‐Yves Loze and W. Kerselaers and has published in prestigious journals such as Annals of the Rheumatic Diseases, Schizophrenia Research and Diabetes Obesity and Metabolism.

In The Last Decade

Miranda Pans

10 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda Pans Belgium 10 244 160 102 55 53 10 493
Susan Gabriel United States 5 196 0.8× 16 0.1× 17 0.2× 25 0.5× 90 1.7× 10 397
Tingjian Yan United States 11 263 1.1× 9 0.1× 288 2.8× 39 0.7× 75 1.4× 26 639
Dennis Meletiche United States 10 218 0.9× 30 0.2× 15 0.1× 23 0.4× 47 0.9× 13 514
Akmal Taher Indonesia 10 172 0.7× 107 0.7× 62 0.6× 12 0.2× 28 0.5× 36 356
Lars Wilkinson Denmark 11 90 0.4× 180 1.1× 114 1.1× 27 0.5× 1 0.0× 23 450
Charles B. Kahn United States 11 153 0.6× 334 2.1× 69 0.7× 32 0.6× 38 0.7× 20 600
Kristina Johnsson Sweden 14 38 0.2× 747 4.7× 368 3.6× 175 3.2× 13 0.2× 21 919
Thomas A. Masterson United States 12 176 0.7× 171 1.1× 69 0.7× 55 1.0× 26 0.5× 63 443
Antonio Martín Morales Spain 8 354 1.5× 577 3.6× 110 1.1× 250 4.5× 36 0.7× 16 895
K.-P. Jünemann Germany 11 172 0.7× 115 0.7× 22 0.2× 22 0.4× 146 2.8× 61 445

Countries citing papers authored by Miranda Pans

Since Specialization
Citations

This map shows the geographic impact of Miranda Pans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Pans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Pans more than expected).

Fields of papers citing papers by Miranda Pans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Pans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Pans. The network helps show where Miranda Pans may publish in the future.

Co-authorship network of co-authors of Miranda Pans

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Pans. A scholar is included among the top collaborators of Miranda Pans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Pans. Miranda Pans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Moyle, Graeme, Jaime Andrade‐Villanueva, Pierre-Marie Girard, et al.. (2012). A Randomized Comparative 96-Week Trial of Boosted Atazanavir versus Continued Boosted Protease Inhibitor in HIV-1 Patients with Abdominal Adiposity. Antiviral Therapy. 17(4). 689–700. 12 indexed citations
2.
Kaine, Jeffrey, Ingrid Strusberg, Ingrid Louw, et al.. (2011). Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Annals of the Rheumatic Diseases. 71(1). 38–44. 63 indexed citations
4.
Taylor, David, Linda Hanssens, Jean‐Yves Loze, et al.. (2008). Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: Results from the STAR study. European Psychiatry. 23(5). 336–343. 13 indexed citations
6.
Wolf, Jürgen, Henrik Lublin, Raimo K. R. Salokangas, et al.. (2007). A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA). Current Medical Research and Opinion. 23(10). 2313–2323. 23 indexed citations
9.
Fujioka, Ken, Miranda Pans, & Steven Joyal. (2003). Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation. Clinical Therapeutics. 25(2). 515–529. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026